• Home
  • Resources
  • Drug Info Center
  • DI Grand Rounds

DI Grand Rounds

Previous Presentations

September 22, 2016
KU School of Pharmacy
Journal Club: Idarucizumab for Dabigatran Reversal
Presenters: Nikol Brucks and Justin Sterbenz, 2017 PharmD Candidates
Watch the presentation

October 27, 2016
KU School of Pharmacy
Journal Club: Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
Resources: Angiotensin-Neprilysin Supplemental Appendix
Presenters: Jocelyn Cotton and Katie Eddy, 2017 PharmD Candidates​

Feburary 16, 2017
KU School of Pharmacy
Journal Club: To view the full article and supplement, Click here.
Presenters: Alex Kraatz and Derrick Grass, 2017 PharmD Candidates

June 30, 2017
KU School of Pharmacy
Journal Club: Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Presenters: Christina Brummett, PharmD Candidate 2018

Upcoming Presentations

July 28, 2017
KU School of Pharmacy
Journal Club: Effect of Cephalexin plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis.
Presenters: Joseph Nguyen, PharmD Candidate 2018

Contact Advisor
2nd among all schools of pharmacy in National Institutes of Health funding
Brings more than $20 million in external funding into the state each year
7 of 19 cancer drugs formulated through the National Cancer Institute were developed at the KU School of Pharmacy
3,000 free flu shots given to needy Kansans during the past 5 years
4,000 living alumni, 63 percent of them living and working in Kansas
KU pharmacists practice in 95 of Kansas’ 105 counties
20th among public schools of pharmacy.
—U.S. News & World Report
$20.2 million NIH research grant earned by Distinguished Professor Jeff Aubé was 2nd largest in Kansas history
100 percent placement after graduation for KU Pharm.D. students
Established in 1885 as the 1st professional program at KU